AHG on Nasdaq
Akso Health Group
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Swvl, MOGU Inc. or Ryde Group Ltd, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
-0.1%Gross margin2
-149.7%Operating margin2
-135.0%Net margin2
-6.4%Revenue growth, 20262
-10.3%Return on equity2
-$12.8MFree cash flow2
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Revenue brought in 50% of the revenue Akso Health Group broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | $2.4M | $14.8M | $13.8M |
| Revenue From Marketing Promotion Service | $14.4M | $13.8M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue70¢$13.8M
- Selling, general and admin20¢$4.0M
- Income tax10¢$2.0M
Out of $13.8M in revenue.2 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Net Revenues | $13.8M | $14.8M | $2.4M |
| Cost of revenue | $13.8M | $15.1M | $2.3M |
| Gross Profit | -$11.3K | -$281.5K | $122.1K |
| Sales and marketing | $168.4K | ||
| General and administrative | $4.0M | $3.6M | $8.6M |
| Impairment of goodwill and intangible assets | $16.7M | $162.4M | |
| Total Operating Expenses | $20.7M | $166.0M | $8.8M |
| LOSS FROM CONTINUING OPERATIONS | -$20.7M | -$166.3M | -$8.6M |
| Other income | $344 | $47.1K | $252.4K |
| Other expense | -$4.7K | -$13.0K | -$114.2K |
| Exchange gain (loss) | $272 | -$26 | -$592.0K |
| Total Other (Expense) Income, net | -$4.1K | $34.1K | -$453.8K |
| LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES | -$20.7M | -$166.3M | -$9.1M |
| (BENEFIT) PROVISON FOR INCOME TAXES | -$2.0M | -$30.8M | $25.0K |
| NET LOSS FROM CONTINUING OPERATIONS | -$18.7M | -$135.5M | -$9.1M |
| Net loss from discontinued operations, net of income taxes | -$3.9K | ||
| Loss from disposal of discontinued operations, net of income taxes | -$395.9K | ||
| Total loss from discontinued operations | -$399.8K | ||
| Less: net loss attributable to non-controlling interest | -$44.6K | -$491.8K | -$57.8K |
| NET LOSS ATTRIBUTABLE TO AKSOS SHAREHOLDERS | -$18.7M | -$135.0M | -$9.5M |
| NET LOSS | -$18.7M | -$135.5M | -$9.5M |
| Foreign currency translation adjustment | $487.4K | $312.1K | -$238.6K |
| COMPREHENSIVE LOSS | -$18.2M | -$135.2M | -$9.8M |
| Less: comprehensive loss attributable to non-controlling interest | -$44.2K | -$494.9K | -$57.4K |
| COMPREHENSIVE LOSS ATTRIBUTABLE TO AKSOS SHAREHOLDERS | -$18.2M | -$134.7M | -$9.7M |
| Basic (in Dollars per share) | $0 | $0 | $0 |
| Diluted (in Dollars per share) | $0 | $0 | $0 |
| Basic (in Dollars per share) | $0.01 | $0.16 | $0.07 |
| Diluted (in Dollars per share) | $0.01 | $0.16 | $0.07 |
| Basic (in Shares) | 2.2B shares | 855.3M shares | 141.5M shares |
| Diluted (in Shares) | 2.2B shares | 855.3M shares | 141.5M shares |
No quarterly figures reported.
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Cash and cash equivalents | $170.6K | $176.2M | $85.2M |
| Accounts receivable, net | $1.3M | $954.2K | |
| Prepayments and other assets | $12.2M | $6.8M | |
| Inventories | $200.1K | $190.2K | |
| Loan receivables | $11.9M | ||
| Advances for capital expenditures | $175.7M | ||
| TOTAL CURRENT ASSETS | $189.5M | $196.1M | |
| Property and equipment, net | $12.0K | $16.1K | |
| Intangible assets, net | $58.3K | $7.9M | |
| Right of use assets | $16.9K | $98.4K | |
| Goodwill | $10.8M | ||
| TOTAL NON-CURRENT ASSETS | $87.2K | $18.8M | |
| TOTAL ASSETS | $189.6M | $215.0M | |
| Accrued expenses and other current liabilities | $1.8M | $1.5M | |
| Contract liabilities | $4.4M | $10.2M | |
| Taxes payable | $93.3K | $33.9K | |
| Loan from third party | $350.5K | ||
| Operating lease liabilities-current | $22.6K | $40.1K | |
| Amount due to related parties | $2.0M | $2.0M | |
| TOTAL CURRENT LIABILITIES | $8.7M | $13.8M | |
| Operating lease liabilities-non-current | $2.6K | $41.7K | |
| Deferred tax liabilities | $1.9M | ||
| TOTAL NON-CURRENT LIABILITIES | $2.6K | $2.0M | |
| TOTAL LIABILITIES | $8.7M | $15.8M | |
| Additional paid-in capital | $405.5M | $405.6M | |
| Treasury stock (1,165,883 shares as of March 31, 2026 and 2025, respectively) | -$4.0M | -$4.0M | |
| Accumulated deficit | -$217.6M | -$198.9M | |
| Accumulated other comprehensive loss | -$3.3M | -$3.8M | |
| TOTAL SHAREHOLDERS EQUITY | $180.9M | $199.1M | |
| Non-controlling interest | -$12.2K | $32.0K | |
| TOTAL EQUITY | $180.9M | $199.2M | $138.4M |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $189.6M | $215.0M | |
| Treasury stock (in Shares) | 1.2M shares | 1.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Net loss from continuing operations | -$18.7M | -$135.5M | -$9.1M |
| Loss from disposal of discontinued operations | $395.9K | ||
| Provision for (recovery of) doubtful accounts | $108.6K | -$100.0K | $7.4M |
| Goodwill impairment | $11.1M | $41.4M | |
| Intangible assets impairment | $5.6M | $121.1M | |
| Depreciation and amortization | $2.4M | $2.1M | |
| Changes in the carrying amount of right-of-use assets | $84.1K | -$98.9K | |
| Deferred tax (benefit) | -$2.0M | -$30.8M | |
| Accrued interests | $527 | ||
| Accounts receivable | -$435.5K | -$859.5K | $327.2K |
| Prepayments and other assets | -$5.4M | -$6.4M | -$130.8K |
| Inventories | $1.5M | ||
| Accounts payable, accrued expenses and other current liabilities | $313.0K | $417.2K | $166.0K |
| Operating lease liabilities | -$56.6K | $82.2K | |
| Contract liabilities | -$5.8M | $9.9M | $220.6K |
| Taxes payable | $59.4K | -$40.5K | -$21.9K |
| Net cash (used in) provided by operating activities from continuing operations | -$12.8M | $1.2M | $705.4K |
| Net cash provided by operating activities from discontinued operations | $645.9K | ||
| NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES | -$12.8M | $1.2M | $1.4M |
| Cash paid for loan originations | -$35.5M | ||
| Acquisitions of property and equipment | -$1.6K | -$154.5K | |
| Cash loans to third parties | -$2.9M | ||
| Cash received from loan repayments | $15.1M | $23.5M | $1.5M |
| Cah paid in connection with acquisition | -$93.8M | -$56.2M | |
| Prepayment for intangible assets development | -$175.7M | ||
| Net cash (used in) investing activities from continuing operations | -$163.5M | -$105.9M | -$54.7M |
| NET CASH (USED IN) INVESTING ACTIVITIES | -$163.5M | -$105.9M | -$54.7M |
| Repayments of loans due to related parties | -$7.7M | ||
| Loan from third parties | $350.0K | ||
| Proceeds from private placement, net of offering costs | $195.9M | $139.3M | |
| Net cash provided by financing activities from continuing operations | $350.0K | $195.9M | $131.7M |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | $350.0K | $195.9M | $131.7M |
| EFFECT OF EXCHANGE RATE CHANGE ON CASH | -$153.5K | -$1.1M | -$1.3M |
| NET (DECREASE) INCREASE IN CASH | -$176.1M | $90.0M | $77.0M |
| Cash paid for income tax | $1.8K | $3.0K | $25.0K |
| Cash paid for interest | $111.6K | ||
| Right-of-use assets obtained in exchange for new lease liabilities | $98.4K | ||
| Modification of right-of-use assets and liabilities | -$60.3K |
Former names
Recent filings
- Jul 23, 202620-F ANNUAL REPORT
- May 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Apr 6, 20263 PRIMARY DOCUMENT
- Mar 30, 20263 PRIMARY DOCUMENT
- Mar 27, 20263 PRIMARY DOCUMENT
- Mar 23, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Mar 18, 20263 PRIMARY DOCUMENT
- Mar 18, 20263 PRIMARY DOCUMENT
- Mar 18, 20263 PRIMARY DOCUMENT
- Feb 10, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Aug 14, 202520-F ANNUAL REPORT
- Jul 31, 2025NT 20-F
- Jun 6, 2025EFFECT
- Jun 5, 2025CORRESP
- May 22, 2025F-3/A AMENDMENT NO. 3 TO FORM F-3
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9